TCL Archive In Brief: Litton Bionetic’s New contract For Operation of FCRC Total $128.8 Million For Five Years October 7, 1977
TCL Archive FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight December 17, 2010